1-3 of 3
Renee M.Y. Barge, MD PhD
Close
Sort by
Journal Articles

Donor Lymphocyte Infusion (DLI) for Mixed Chimerism 6 Months after T Cell Depleted Allogeneic Stem Cell Transplantation (TCD alloSCT) May Prevent Relapse.

Erik W.A. Marijt, MD, PhD, Peter A. Von Dem Borne, MD PhD, Renee M.Y. Barge, MD PhD, Piette P. Deutz, M. Floor Beaumont, C.W.J. Ingrid Starrenburg, Willem E. Fibbe, MD PhD, Roelof Willemze, MD PhD, J.H. Frederik Falkenburg, MD PhD
Journal: Blood
Blood (2006) 108 (11): 3674.
https://doi.org/10.1182/blood.V108.11.3674.3674
Published: 2006
Journal Articles

Adoptive Immunotherapy with Donor Lymphocyte Infusions after T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia.

Renee M.Y. Barge, MD, PhD, Eva Steel, MD, Ingrid Starrenburg, Floor Beaumont, Willem M. Smit, MD, PhD, Martyn Ronald Schaafsma, MD, PhD, Ward Posthuma, MD, PhD, Willem E. Fibbe, MD, PhD, Frederik Falkenburg, MD, PhD, Roelof Willemze, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2014.
https://doi.org/10.1182/blood.V106.11.2014.2014
Published: 2005
Journal Articles

A Two Step Nonmyeloablative Allogeneic Transplantation Protocol Using In Vitro T-Cell Depleted Mobilized Stem Cells Followed by Donor Lymphocyte Infusions in Patients with Advanced CLL.

Renee M.Y. Barge, MD, PhD, Mels Hoogendoorn, MD, Erik W.A. Marijt, MD, PhD, Floor Beaumont, Ingrid Starrenburg, Willem Smit, MD, PhD, Ward Posthuma, MD, PhD, Willem E. Fibbe, MD, PhD, Frederik Falkenburg, MD, PhD, Roelof Willemze, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5396.
https://doi.org/10.1182/blood.V106.11.5396.5396
Published: 2005